Please login to the form below

Not currently logged in
Email:
Password:

addiction

This page shows the latest addiction news and features for those working in and with pharma, biotech and healthcare.

Heron boosted by new data for ‘breakthrough’ pain drug

Heron boosted by new data for ‘breakthrough’ pain drug

The reduction in opioid use is another important facet of the new therapy, given the US’s current epidemic of opioid abuse – with addiction in some cases occurring in people initially

Latest news

More from news
Approximately 3 fully matching, plus 57 partially matching documents found.

Latest Intelligence

  • Revenue down the back of the beanbag Revenue down the back of the beanbag

    It’s become a boardroom agenda item; one where someone typically feels obliged to comment on his or her nephew’s smartphone addiction and low attention span.

  • Deal Watch January 2018

    Licence. 350. Addex Therapeutics/ Indivior. ADX71441, selective positive allosteric modulator (PAM) for addiction (pc).

  • Change in the pharma industry is inevitable Change in the pharma industry is inevitable

    profiting from the life-shortening addiction they have encouraged.

  • Pharma deals during November 2014 Pharma deals during November 2014

    Indivior will not be without its challenges as sales of its off-patent opioid addiction treatment Suboxone continue to slump.

  • Pharma deals during May 2014 Pharma deals during May 2014

    All options continue to be considered. A capital markets solution is emerging as a strong option.” The difficulty is that Suboxone (for treatment of drug addiction) sales are being hit by ... It is therefore very surprising that this month Reckitt

More from intelligence
Approximately 0 fully matching, plus 6 partially matching documents found.

Latest appointments

  • Hanover appoints new associate director Hanover appoints new associate director

    Previously he spent five years in-house with Schering-Plough and MSD, working on brand communications across immunology, CVD, respiratory, virology and addiction portfolios.

More from appointments
Approximately 0 fully matching, plus 1 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 5 fully matching, plus 10 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
90TEN Healthcare

90TEN is an award-winning healthcare communications consultancy that puts people at the heart of everything we do. Our Life.Changing. campaigns...

Latest intelligence

Developing advocacy in the pharmaceutical industry.
The importance of advocacy programmes...
GDPR and events. What does the pharma industry need to know?
Many people in the pharma industry still aren’t following the rules set out by the GDPR when it comes to running events and attending tradeshows. But with eye-watering fines for...
Digital trends in B2B sales - how far behind is Pharma?
The modern approach to B2B sales is data-driven, and enabled by digital tools....

Infographics